Pirfenidoneone

DRUG2 trials

Sponsors

Boehringer Ingelheim, M.D. Anderson Cancer Center

Conditions

FibrosisFibrosis SyndromeHead &Amp; Neck CancerLymphedemaPulmonary Fibrosis

Phase 2

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

CompletedNCT01417156

Boehringer IngelheimPulmonary Fibrosis

Start: 2011-09-30End: 2015-10-31Updated: 2017-03-06

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

RecruitingNCT06912763

M.D. Anderson Cancer CenterFibrosis, Fibrosis Syndrome, Head &Amp; Neck Cancer +1

Start: 2025-08-08End: 2031-07-31Target: 250Updated: 2026-07-24